Early cognitive, structural, and microstructural changes in presymptomatic C9orf72 carriers younger than 40 years

A Bertrand, J Wen, D Rinaldi, M Houot, S Sayah… - JAMA …, 2018 - jamanetwork.com
Importance Presymptomatic carriers of chromosome 9 open reading frame 72 (C9orf72)
mutation, the most frequent genetic cause of frontotemporal lobar degeneration and …

Triheptanoin improves brain energy metabolism in patients with Huntington disease

IM Adanyeguh, D Rinaldi, PG Henry, S Caillet… - Neurology, 2015 - AAN Enterprises
Objective: Based on our previous work in Huntington disease (HD) showing improved
energy metabolism in muscle by providing substrates to the Krebs cycle, we wished to …

[HTML][HTML] Autosomal dominant cerebellar ataxias: imaging biomarkers with high effect sizes

IM Adanyeguh, V Perlbarg, PG Henry, D Rinaldi… - NeuroImage: Clinical, 2018 - Elsevier
Objective As gene-based therapies may soon arise for patients with spinocerebellar ataxia
(SCA), there is a critical need to identify biomarkers of disease progression with effect sizes …

Presymptomatic spinal cord pathology in c9orf72 mutation carriers: A longitudinal neuroimaging study

G Querin, P Bede, MM El Mendili, M Li… - Annals of …, 2019 - Wiley Online Library
Objective C9orf72 hexanucleotide repeats expansions account for almost half of familial
amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) cases. Recent …

Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency

F Mochel, E Hainque, D Gras, IM Adanyeguh… - Journal of Neurology …, 2016 - jnnp.bmj.com
Objective On the basis of our previous work with triheptanoin, which provides key substrates
to the Krebs cycle in the brain, we wished to assess its therapeutic effect in patients with …

Progression of behavioral disturbances and neuropsychiatric symptoms in patients with genetic frontotemporal dementia

A Benussi, E Premi, S Gazzina, C Brattini… - JAMA Network …, 2021 - jamanetwork.com
Importance Behavioral disturbances are core features of frontotemporal dementia (FTD);
however, symptom progression across the course of disease is not well characterized in …

In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7

IM Adanyeguh, PG Henry, TM Nguyen… - Movement …, 2015 - Wiley Online Library
Spinocerebellar ataxias (SCAs) belong to polyglutamine repeat disorders and are
characterized by a predominant atrophy of the cerebellum and the pons. Proton magnetic …

Neurite density is reduced in the presymptomatic phase of C9orf72 disease

J Wen, H Zhang, DC Alexander… - Journal of Neurology …, 2019 - jnnp.bmj.com
Objective To assess the added value of neurite orientation dispersion and density imaging
(NODDI) compared with conventional diffusion tensor imaging (DTI) and anatomical MRI to …

[HTML][HTML] Differential early subcortical involvement in genetic FTD within the GENFI cohort

M Bocchetta, EG Todd, G Peakman, DM Cash… - NeuroImage: Clinical, 2021 - Elsevier
Background Studies have previously shown evidence for presymptomatic cortical atrophy in
genetic FTD. Whilst initial investigations have also identified early deep grey matter volume …

Plasma NfL levels and longitudinal change rates in C9orf72 and GRN-associated diseases: from tailored references to clinical applications

D Saracino, K Dorgham, A Camuzat… - Journal of Neurology …, 2021 - jnnp.bmj.com
Objective Neurofilament light chain (NfL) is a promising biomarker in genetic frontotemporal
dementia (FTD) and amyotrophic lateral sclerosis (ALS). We evaluated plasma …